Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN20203855
ISRCTN20203855
Completed
未知

Evaluation of the effects of two dementia-specific case conferences within German nursing homes using a stepped-wedged randomized controlled trial

Stiftung Wohlfahrtspflege Nordrhein-Westfalen [Public Welfare Foundation North Rhine-Westphalia]0 sites413 target enrollmentJuly 10, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Stiftung Wohlfahrtspflege Nordrhein-Westfalen [Public Welfare Foundation North Rhine-Westphalia]
Enrollment
413
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2014 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/25118091 2014 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/25496425 2019 results in: https://www.sciencedirect.com/science/article/abs/pii/S0020748919302421 (added 02/10/2019) 2019 process evaluation in: https://www.ncbi.nlm.nih.gov/pubmed/30642387 (added 02/10/2019)

Registry
who.int
Start Date
July 10, 2013
End Date
October 31, 2015
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Stiftung Wohlfahrtspflege Nordrhein-Westfalen [Public Welfare Foundation North Rhine-Westphalia]

Eligibility Criteria

Inclusion Criteria

  • •The following inclusion criteria were set for institution and patient level of the trial.
  • •Institution Level
  • •1\. At least two wards of one nursing home must take part in the study that provide together at least 30 residents with dementia
  • •2\. The care of the residents have to take place most of the day in their ward
  • •Patient level
  • •1\. Informed consent
  • •2\. Diagnosis of dementia
  • •3\. Living not less than 14 days in the ward
  • •According to the Federal Statistical Office we expect that most of the patients are \> 65 years and around 70% of the patients in our study sample will be women and 30% men.

Exclusion Criteria

  • •The following exclusion criteria were set for institution and patient level of the trial
  • •Institution level
  • •1\. Nursing homes size \< 30
  • •2\. Some kind of day care is integrated in the institution for people with dementia
  • •3\. Reconstruction work on the participated unit and participation in any other research project at the same time that bond personal resources
  • •Patient level
  • •1\. Schizophrenia or any other kind of psychiatric diseases (found in the medical documentation)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type DementiaAlzheimer Type Dementia
NCT01245530Whanin Pharmaceutical Company280
Completed
Not Applicable
10/66 Dementia Research Group randomised controlled trial: helping carers to care - ArgentinaDementia syndromeMental and Behavioural DisordersDementia
ISRCTN9513543310/66 Dementia Research Group (UK)60
Completed
Not Applicable
10/66 Dementia Research Group randomised controlled trial: helping carers to care - PeruDementia syndromeMental and Behavioural DisordersDementia
ISRCTN6635540210/66 Dementia Research Group (UK)60
Completed
Not Applicable
10/66 Dementia Research Group randomised controlled trial: helping carers to care - MexicoDementia syndromeMental and Behavioural DisordersDementia
ISRCTN4106201110/66 Dementia Research Group (UK)60
Completed
Not Applicable
10/66 Dementia Research Group randomised controlled trial: helping carers to care - Venezuela
ISRCTN9492181510/66 Dementia Research Group (UK)60